Phylogica is one of the leading peptide drug discovery companies, whose libraries contain billions of unique peptides known as Phylomer peptides; they represent a rich source of biologically active drug leads. These peptides are known to have exceptional structural stability, specificity and affinity, thereby giving them the potential to address disease targets. In a pilot study, it was proven that certain peptides which are associated with the Omomyc drug, ...Thursday 9 April 2015
Phylogica Peptide Fusion Kills Aggressive Breast Cancer Cells
Phylogica is one of the leading peptide drug discovery companies, whose libraries contain billions of unique peptides known as Phylomer peptides; they represent a rich source of biologically active drug leads. These peptides are known to have exceptional structural stability, specificity and affinity, thereby giving them the potential to address disease targets. In a pilot study, it was proven that certain peptides which are associated with the Omomyc drug, ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment